| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4-bisphosphate binding | 6.39e-05 | 35 | 124 | 4 | GO:0043325 | |
| GeneOntologyMolecularFunction | choline kinase activity | 1.14e-04 | 3 | 124 | 2 | GO:0004103 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.78e-04 | 18 | 124 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | ethanolamine kinase activity | 2.28e-04 | 4 | 124 | 2 | GO:0004305 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate binding | 2.42e-04 | 49 | 124 | 4 | GO:0005547 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 5.47e-04 | 26 | 124 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 6.84e-04 | 28 | 124 | 3 | GO:0051959 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.37e-04 | 17 | 126 | 3 | GO:0001518 | |
| Domain | Na_channel_asu | 3.48e-05 | 10 | 126 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 3.48e-05 | 10 | 126 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 3.48e-05 | 10 | 126 | 3 | PF06512 | |
| Domain | AnnexinVIII | 4.52e-05 | 2 | 126 | 2 | IPR009115 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.03e-04 | 14 | 126 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.03e-04 | 14 | 126 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.03e-04 | 14 | 126 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.03e-04 | 14 | 126 | 3 | PF08393 | |
| Domain | MT | 1.03e-04 | 14 | 126 | 3 | PF12777 | |
| Domain | AAA_8 | 1.03e-04 | 14 | 126 | 3 | PF12780 | |
| Domain | DHC_fam | 1.29e-04 | 15 | 126 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 1.29e-04 | 15 | 126 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.29e-04 | 15 | 126 | 3 | IPR004273 | |
| Domain | SAPS | 1.35e-04 | 3 | 126 | 2 | IPR007587 | |
| Domain | SAPS | 1.35e-04 | 3 | 126 | 2 | PF04499 | |
| Domain | - | 3.14e-04 | 20 | 126 | 3 | 3.60.15.10 | |
| Domain | Metallo-B-lactamas | 3.14e-04 | 20 | 126 | 3 | IPR001279 | |
| Domain | Ion_trans_dom | 1.05e-03 | 114 | 126 | 5 | IPR005821 | |
| Domain | Ion_trans | 1.05e-03 | 114 | 126 | 5 | PF00520 | |
| Domain | Olfact_rcpt | 1.40e-03 | 393 | 126 | 9 | IPR000725 | |
| Domain | ANX | 3.35e-03 | 13 | 126 | 2 | SM00335 | |
| Domain | Annexin_repeat_CS | 3.35e-03 | 13 | 126 | 2 | IPR018252 | |
| Domain | Annexin | 3.35e-03 | 13 | 126 | 2 | PF00191 | |
| Domain | Annexin_repeat | 3.35e-03 | 13 | 126 | 2 | IPR018502 | |
| Domain | ANNEXIN | 3.35e-03 | 13 | 126 | 2 | PS00223 | |
| Domain | - | 3.35e-03 | 13 | 126 | 2 | 1.10.220.10 | |
| Domain | Thioredoxin | 3.35e-03 | 13 | 126 | 2 | IPR005746 | |
| Domain | Annexin | 3.90e-03 | 14 | 126 | 2 | IPR001464 | |
| Domain | ATPase_dyneun-rel_AAA | 3.90e-03 | 14 | 126 | 2 | IPR011704 | |
| Domain | AAA_5 | 3.90e-03 | 14 | 126 | 2 | PF07728 | |
| Domain | Lactamase_B | 4.48e-03 | 15 | 126 | 2 | SM00849 | |
| Domain | Thioredoxin_CS | 5.75e-03 | 17 | 126 | 2 | IPR017937 | |
| Domain | Channel_four-helix_dom | 6.73e-03 | 57 | 126 | 3 | IPR027359 | |
| Domain | - | 6.73e-03 | 57 | 126 | 3 | 1.20.120.350 | |
| Pubmed | TCF20 IPO7 MAP1B DSP NUP98 NARS1 ME2 TASOR2 PDIA4 NF1 SYNE2 CNOT1 DYNC1H1 PPP6R3 | 1.30e-07 | 653 | 127 | 14 | 22586326 | |
| Pubmed | VAPB SCN11A LARP6 MAP1B DSP PARP8 NUP98 PSMD3 APOB XPC NEB ECE1 TASOR2 PDIA4 TRNT1 SHANK2 CHD5 SYNE2 LIMCH1 DOP1A | 2.90e-07 | 1442 | 127 | 20 | 35575683 | |
| Pubmed | NRIP1 TCF20 IPO7 XPC NEB IFIT1 DNAH7 EXD3 NF1 SYNE2 USP39 CNOT1 ACSS3 | 6.64e-07 | 638 | 127 | 13 | 31182584 | |
| Pubmed | VAPB IPO7 MAP1B DSP LARS1 NARS1 PSMD3 SCYL2 PDIA4 TXNL1 CNOT1 FAM135A DYNC1H1 | 2.10e-06 | 708 | 127 | 13 | 39231216 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TCF20 MAP1B DSP PARP8 FAM53C DNAH7 WDR59 NF1 DLC1 PLEKHG3 SYNE2 LIMCH1 EDRF1 DOP1A | 3.42e-06 | 861 | 127 | 14 | 36931259 |
| Pubmed | IPO7 DSP LARS1 PSMD3 APOB ECE1 IFIT1 SORCS1 SYNE2 OR10K1 LIMCH1 GALNT5 DYNC1H1 | 4.16e-06 | 754 | 127 | 13 | 35906200 | |
| Pubmed | NRIP1 LARP6 CORO2A DSP LARS1 NARS1 XPC FAM53C WDR59 RYR3 SCYL2 JAK1 UBE4A LRRCC1 PALS2 BTRC DYNC1H1 | 4.63e-06 | 1285 | 127 | 17 | 35914814 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TCF20 IPO7 MAP1B DSP LARS1 NUP98 PSMD3 PDIA4 NF1 PLEKHG3 SYNE2 USP39 CPSF2 CNOT1 DYNC1H1 | 5.29e-06 | 1024 | 127 | 15 | 24711643 |
| Pubmed | AHI1 ERCC4 RNMT CENPN APOB TACC2 ME2 PDIA4 TRNT1 NPHP3 PAXBP1 CPSF2 CNOT1 FAM135A NCKAP1L | 1.04e-05 | 1084 | 127 | 15 | 11544199 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 1364010 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 24769558 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 25535740 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 23583712 | ||
| Pubmed | Cooperative binding promotes demand-driven recruitment of AnxA8 to cholesterol-containing membranes. | 1.32e-05 | 2 | 127 | 2 | 29306076 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 22474336 | ||
| Pubmed | Bone matrix regulates osteoclast differentiation and annexin A8 gene expression. | 1.32e-05 | 2 | 127 | 2 | 21344395 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 16203777 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 15928709 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 11144347 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 11917092 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 25803307 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 28391287 | ||
| Pubmed | 1.68e-05 | 14 | 127 | 3 | 9373155 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | VAPB IPO7 DSP LARS1 NUP98 PSMD3 APOB GRM1 ME2 PDIA4 UBE4A PAXBP1 NF1 USP39 GALNT5 CNOT1 DYNC1H1 | 1.77e-05 | 1425 | 127 | 17 | 30948266 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | USP17L7 VAPB IPO7 MAP1B NUP98 PSMD3 WDR59 TXNL1 USP39 PPP6R2 CNOT1 BTRC PPP6R3 WDR48 | 1.94e-05 | 1005 | 127 | 14 | 19615732 |
| Pubmed | VAPB IPO7 MAP1B CORO2A LARS1 NARS1 PSMD3 IFIT1 UBE4A PLEKHG3 SYNE2 LIMCH1 USP39 CNOT1 BTRC DYNC1H1 PPP6R3 | 2.02e-05 | 1440 | 127 | 17 | 30833792 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 2.09e-05 | 313 | 127 | 8 | 38270169 | |
| Pubmed | 2.19e-05 | 153 | 127 | 6 | 10718198 | ||
| Pubmed | VAPB UBR2 IPO7 DSP NUP98 PSMD3 PDIA4 SYNE2 CPSF2 PPP6R2 CNOT1 BTRC PPP6R3 WDR48 | 3.10e-05 | 1049 | 127 | 14 | 27880917 | |
| Pubmed | VAPB SH3BP1 NUP98 PSMD3 WDR59 PDIA4 DLC1 PLEKHG3 PPIE USP39 CPSF2 BTRC PPP6R3 | 3.23e-05 | 916 | 127 | 13 | 32203420 | |
| Pubmed | 3.31e-05 | 334 | 127 | 8 | 30425250 | ||
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | 3.76e-05 | 340 | 127 | 8 | 11875048 | |
| Pubmed | 3.76e-05 | 340 | 127 | 8 | 11802173 | ||
| Pubmed | CCRK depletion inhibits glioblastoma cell proliferation in a cilium-dependent manner. | 3.96e-05 | 3 | 127 | 2 | 23743448 | |
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 34269180 | ||
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 11727199 | ||
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 25299066 | ||
| Pubmed | Specific expression of annexin A8 in adult murine stratified epithelia. | 3.96e-05 | 3 | 127 | 2 | 17082908 | |
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 38225265 | ||
| Pubmed | GSK3-β Stimulates Claspin Degradation via β-TrCP Ubiquitin Ligase and Alters Cancer Cell Survival. | 3.96e-05 | 3 | 127 | 2 | 31362447 | |
| Pubmed | Human SNM1A and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair. | 3.96e-05 | 3 | 127 | 2 | 21896658 | |
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 18838045 | ||
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 2530088 | ||
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 15302875 | ||
| Pubmed | 3.99e-05 | 343 | 127 | 8 | 32295537 | ||
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 4.08e-05 | 344 | 127 | 8 | 30333137 | |
| Pubmed | IPO7 CYP51A1 PSMD3 ME2 BCS1L ACSL1 UBE4A CNOT1 DYNC1H1 PPP6R3 | 4.20e-05 | 560 | 127 | 10 | 35241646 | |
| Pubmed | 4.25e-05 | 346 | 127 | 8 | 14611657 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 4.55e-05 | 256 | 127 | 7 | 33397691 | |
| Pubmed | 5.01e-05 | 55 | 127 | 4 | 33067418 | ||
| Pubmed | 6.96e-05 | 22 | 127 | 3 | 15733672 | ||
| Pubmed | VAPB MAP1B DSP ANXA8L1 DGKG PSMD3 ANXA8 TACC2 TXNL1 NF1 SHANK2 PPP6R2 CNOT1 BTRC | 7.51e-05 | 1139 | 127 | 14 | 36417873 | |
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 21986944 | ||
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 16823510 | ||
| Pubmed | Regulated degradation of FANCM in the Fanconi anemia pathway during mitosis. | 7.90e-05 | 4 | 127 | 2 | 19270156 | |
| Pubmed | RPA activates the XPF-ERCC1 endonuclease to initiate processing of DNA interstrand crosslinks. | 7.90e-05 | 4 | 127 | 2 | 28607004 | |
| Pubmed | Role of Claspin in regulation of nucleotide excision repair factor DDB2. | 7.90e-05 | 4 | 127 | 2 | 17196446 | |
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 16885022 | ||
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 16885021 | ||
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 19621075 | ||
| Pubmed | 7.90e-05 | 4 | 127 | 2 | 15762842 | ||
| Pubmed | 8.69e-05 | 493 | 127 | 9 | 15368895 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | VAPB ANXA8L1 NUP98 ANXA8 TACC2 XPC TASOR2 PDIA4 PAXBP1 PER3 PPIE USP39 CNOT1 DYNC1H1 | 8.70e-05 | 1155 | 127 | 14 | 20360068 |
| Pubmed | 8.82e-05 | 494 | 127 | 9 | 26831064 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CDK20 VAPB MAK AHI1 LARS1 FAM53C SCYL2 ACSL1 EFHC1 NPHP3 NF1 CNOT1 EDRF1 DYNC1H1 WDR48 | 9.94e-05 | 1321 | 127 | 15 | 27173435 |
| Pubmed | 1.14e-04 | 206 | 127 | 6 | 22174317 | ||
| Pubmed | Identification of 14-3-3epsilon substrates from embryonic murine brain. | 1.28e-04 | 132 | 127 | 5 | 16944949 | |
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 1.31e-04 | 5 | 127 | 2 | 22875929 | |
| Pubmed | Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk. | 1.31e-04 | 5 | 127 | 2 | 18544627 | |
| Pubmed | 1.31e-04 | 5 | 127 | 2 | 16258177 | ||
| Pubmed | Tissue specific mutagenic and carcinogenic responses in NER defective mouse models. | 1.31e-04 | 5 | 127 | 2 | 16769089 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | VAPB IPO7 MAP1B DSP PSMD3 SORCS1 PDIA4 LIMCH1 DYNC1H1 PPP6R3 | 1.38e-04 | 647 | 127 | 10 | 26618866 |
| Pubmed | 1.50e-04 | 415 | 127 | 8 | 16385451 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | RNMT TCF20 MAP1B DSP CYP51A1 XPC TXNL1 PAXBP1 PCDH15 USP39 CPSF2 CNOT1 DYNC1H1 | 1.72e-04 | 1082 | 127 | 13 | 38697112 |
| Pubmed | 1.78e-04 | 76 | 127 | 4 | 29599191 | ||
| Pubmed | DNAH3 MAP1B DSP NARS1 DGKG PSMD3 IFIT1 PDIA4 NF1 PPP6R2 DYNC1H1 | 1.82e-04 | 803 | 127 | 11 | 36517590 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.90e-04 | 430 | 127 | 8 | 35044719 | |
| Pubmed | 1.97e-04 | 6 | 127 | 2 | 16029194 | ||
| Pubmed | 1.97e-04 | 6 | 127 | 2 | 18709642 | ||
| Pubmed | Are voltage-dependent ion channels involved in the endothelial cell control of vasomotor tone? | 1.97e-04 | 6 | 127 | 2 | 17513486 | |
| Pubmed | 1.97e-04 | 6 | 127 | 2 | 9694898 | ||
| Pubmed | Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China. | 1.97e-04 | 6 | 127 | 2 | 15849729 | |
| Pubmed | 1.97e-04 | 6 | 127 | 2 | 20065038 | ||
| Pubmed | Human cytomegalovirus UL138 interaction with USP1 activates STAT1 in infection. | 1.97e-04 | 6 | 127 | 2 | 37289831 | |
| Pubmed | 1.97e-04 | 6 | 127 | 2 | 20199546 | ||
| Pubmed | 1.97e-04 | 6 | 127 | 2 | 23711479 | ||
| Pubmed | 1.97e-04 | 6 | 127 | 2 | 16399771 | ||
| Pubmed | Interindividual variation in nucleotide excision repair genes and risk of endometrial cancer. | 1.97e-04 | 6 | 127 | 2 | 16284373 | |
| Pubmed | 1.97e-04 | 6 | 127 | 2 | 19434073 | ||
| Pubmed | STK40 Is a Pseudokinase that Binds the E3 Ubiquitin Ligase COP1. | 1.98e-04 | 31 | 127 | 3 | 28089446 | |
| Pubmed | VAPB MAP1B CORO2A DSP LARS1 NARS1 PSMD3 GRM1 NF1 SHANK2 LRRCC1 LIMCH1 PPP6R2 CNOT1 DYNC1H1 | 2.37e-04 | 1431 | 127 | 15 | 37142655 | |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | 2.60e-04 | 571 | 127 | 9 | 37167062 | |
| Pubmed | Polymorphisms in DNA damage response genes and head and neck cancer risk. | 2.75e-04 | 7 | 127 | 2 | 20429839 | |
| Pubmed | DNA repair gene variants associated with benign breast disease in high cancer risk women. | 2.75e-04 | 7 | 127 | 2 | 19124519 | |
| Pubmed | 2.75e-04 | 7 | 127 | 2 | 16492920 | ||
| Pubmed | Nucleotide excision repair pathway genes and oral premalignant lesions. | 2.75e-04 | 7 | 127 | 2 | 17575242 | |
| Pubmed | 2.75e-04 | 7 | 127 | 2 | 9434938 | ||
| Pubmed | Genetic variation in the nucleotide excision repair pathway and bladder cancer risk. | 2.75e-04 | 7 | 127 | 2 | 16537713 | |
| Pubmed | 2.75e-04 | 7 | 127 | 2 | 12397072 | ||
| Pubmed | 2.75e-04 | 7 | 127 | 2 | 10447254 | ||
| Cytoband | 6p24 | 4.54e-05 | 4 | 127 | 2 | 6p24 | |
| GeneFamily | Protein phosphatase 6 regulatory subunits | 3.09e-04 | 6 | 83 | 2 | 699 | |
| GeneFamily | WD repeat domain containing|Xeroderma pigmentosum complementation groups|Nucleotide excision repair | 5.73e-04 | 8 | 83 | 2 | 1125 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 7.34e-04 | 9 | 83 | 2 | 1203 | |
| GeneFamily | Annexins|Endogenous ligands | 1.57e-03 | 13 | 83 | 2 | 404 | |
| GeneFamily | Dyneins, axonemal | 2.71e-03 | 17 | 83 | 2 | 536 | |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP | 2.39e-06 | 176 | 127 | 8 | M2981 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP | 5.31e-06 | 196 | 127 | 8 | M5381 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.08e-07 | 178 | 127 | 7 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 1.54e-06 | 196 | 127 | 7 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 1.54e-06 | 196 | 127 | 7 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.64e-06 | 198 | 127 | 7 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.76e-06 | 200 | 127 | 7 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.76e-06 | 200 | 127 | 7 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 4.79e-06 | 151 | 127 | 6 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | Control-B_intermediate-10|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.17e-06 | 162 | 127 | 6 | aa80452b972bb8ad3670ffaba4ce26fadb33b185 | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 8.52e-06 | 167 | 127 | 6 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 182 | 127 | 6 | 678eadd57e7e830fc2bf9fd35616d3badce01705 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 182 | 127 | 6 | 8d1229fa5aa6e2e38f2ac6fe4f4dc89752fe9344 | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.43e-05 | 183 | 127 | 6 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | (7)_Epithelial-H_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.48e-05 | 184 | 127 | 6 | 1f76b37c265b519171b767a52d48f31f0cdc4a3c | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 184 | 127 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 184 | 127 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 184 | 127 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Control-Epithelial-ATI|World / Disease state, Lineage and Cell class | 1.53e-05 | 185 | 127 | 6 | 0563d5042bb96ecce8446fbf26d05ef7a45e23c5 | |
| ToppCell | Control-Epithelial-ATI|Control / Disease state, Lineage and Cell class | 1.62e-05 | 187 | 127 | 6 | fdd1c57b61ca9392ac27661a82729f37593df63c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.62e-05 | 187 | 127 | 6 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.83e-05 | 191 | 127 | 6 | e8d56e9f43943e9cc4dce83f2c234f19c2dd487d | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.83e-05 | 191 | 127 | 6 | 52e8d7dfaf1ebb6df8bf3a1f4546af59faa67657 | |
| ToppCell | Control-B_intermediate-10|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.88e-05 | 192 | 127 | 6 | 224bd958369ba8fa0d7be2126f7dc61c9f6ac19d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.94e-05 | 193 | 127 | 6 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 2.05e-05 | 195 | 127 | 6 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 2.05e-05 | 195 | 127 | 6 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 2.05e-05 | 195 | 127 | 6 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 2.11e-05 | 196 | 127 | 6 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.17e-05 | 197 | 127 | 6 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.24e-05 | 198 | 127 | 6 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 2.24e-05 | 198 | 127 | 6 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.24e-05 | 198 | 127 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Severe-B_intermediate-10|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.24e-05 | 198 | 127 | 6 | dfae26c3513a82bb7cb8dadbfcea2a1f420b1bab | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.24e-05 | 198 | 127 | 6 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.30e-05 | 199 | 127 | 6 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.30e-05 | 199 | 127 | 6 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.30e-05 | 199 | 127 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.37e-05 | 200 | 127 | 6 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.37e-05 | 200 | 127 | 6 | dc8702e3cb4ac8c1a9849fc8abf8777f12d55b0b | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R---L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.37e-05 | 200 | 127 | 6 | d92d51021ab6d78e9c8f89f7c150181004dcbcbd | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.37e-05 | 200 | 127 | 6 | cbbb9044283ff9ab63bbfc24d7a9f006b1372705 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.37e-05 | 200 | 127 | 6 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.37e-05 | 200 | 127 | 6 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.37e-05 | 200 | 127 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.37e-05 | 200 | 127 | 6 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.37e-05 | 200 | 127 | 6 | a3e36bbeed19431d07bc205f14f4e0f12bd8f730 | |
| ToppCell | Control-B_activate-7|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.57e-05 | 130 | 127 | 5 | d3343c19d61928f18e7d707eda5dec6e0fd2a9a2 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 6.83e-05 | 28 | 127 | 3 | 456cf2e0a6ea59c279efc77a1d02e5572196cb6b | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.06e-05 | 150 | 127 | 5 | 744050a1b665c6989f37141348af3df7579a73c9 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.06e-05 | 150 | 127 | 5 | 6f7087a051a2f05c5611ff65a945c01736d5ec2b | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.52e-05 | 152 | 127 | 5 | 87a7116d0064a6051bdf28ce1e48bfc168273e66 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Tnc|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.00e-05 | 154 | 127 | 5 | 0066b2b8cfc74603e97f271ef5efc7ec512110dc | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.00e-05 | 154 | 127 | 5 | e94cd11488003347120eacd3ced0a8923ed09ccc | |
| ToppCell | AT1-AT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 9.02e-05 | 158 | 127 | 5 | 3bc51cfd37b289cc3e866b54ce55a298e5eff690 | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.58e-05 | 160 | 127 | 5 | 67ee7a314d7d4d3ea206e0158083f36f6dd7e80b | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.58e-05 | 160 | 127 | 5 | ec81814f3a475ba9bc049cb793bf93bc0b650d37 | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.58e-05 | 160 | 127 | 5 | 759749f708c3a2b36692d42499f19aff937e592f | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic-erythroblast|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.58e-05 | 160 | 127 | 5 | fc76337ad766c859db390ef8b6fb9caeaace3a56 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.11e-04 | 165 | 127 | 5 | 1c630f9ecde2e0243922a2be4b1ab5adcfcb0893 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Stem_cells-ectodermal/neuroectodermal-like_cells|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.14e-04 | 166 | 127 | 5 | d7e49416426a62801ea1062d7aaf55ea622ae118 | |
| ToppCell | normal_Lung-Fibroblasts-Mesothelial_cells|Fibroblasts / Location, Cell class and cell subclass | 1.17e-04 | 167 | 127 | 5 | 892a2dc83ab5de5a1016402f8e95d2aabf651326 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.20e-04 | 168 | 127 | 5 | a1755afa2cc50960ba60e07d84d61be429cdea72 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 170 | 127 | 5 | 545c755b057871b7a22221a049a63a61713dad1d | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 172 | 127 | 5 | 356a66cd9303470e427005cc67fdd22a2c4bf971 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 172 | 127 | 5 | 46fadeee483fdf8402df92ec98575a09c6c15b16 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-04 | 172 | 127 | 5 | 1171e754fd503a0c1152162fcc12a115088a08c7 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-suprabasal_interpapillary|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 172 | 127 | 5 | 6ece9bb9f31685c918ca4cb7b82cf6ad1cad48af | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 172 | 127 | 5 | 438d2e7f1897668a14d85ca70722e5d0102606dc | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.42e-04 | 174 | 127 | 5 | c988471207ba06195bc3e41056435e8c31c20bbe | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.42e-04 | 174 | 127 | 5 | 59ccc5a82507463e0a316ba6286cb25ec1a4091b | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.42e-04 | 174 | 127 | 5 | 9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.50e-04 | 176 | 127 | 5 | 0710689e66deba179b0a8038cdd56b4834984f12 | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 177 | 127 | 5 | 7bc92314b22a876296a4e2db51e7fb0fdfd69379 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.54e-04 | 177 | 127 | 5 | f30d757ee8db7e10d547498dab6560473c6ed7c0 | |
| ToppCell | Severe-B_intermediate-10|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.58e-04 | 178 | 127 | 5 | b7374a97c51239782bed658381a02cb1b3d9bf66 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.58e-04 | 178 | 127 | 5 | 6f61490d79cd1727ed2d5cc673823dd4efdafac1 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 178 | 127 | 5 | a3176b2b335db22bb0fb71aafa5d7a287809396e | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.62e-04 | 179 | 127 | 5 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | facs|World / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 179 | 127 | 5 | 8001db3044e8657980e24422377c4fdb0d7b323e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 179 | 127 | 5 | 78fae47ec9bff4e0159a86a281e831d7f8ee925a | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.62e-04 | 179 | 127 | 5 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic-granulocyte|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.62e-04 | 179 | 127 | 5 | 140dd7dbac48f5f07279f31bf971d7fbd41fa18b | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 180 | 127 | 5 | 43fd5c498a87bb078d101298b472656f3294686a | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.70e-04 | 181 | 127 | 5 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | 11.5-Airway-Immune-Hematopoietic,_B_Cells|Airway / Age, Tissue, Lineage and Cell class | 1.70e-04 | 181 | 127 | 5 | 727344d7b2953568b7b3463398c7d56878cf2c2b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 182 | 127 | 5 | 587636c0f127231de21acd8aa632b74ff22ca8c2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-04 | 182 | 127 | 5 | adfadd7893e74b3002f13f00875e3667d3493e0c | |
| ToppCell | COPD-Epithelial-ATI|World / Disease state, Lineage and Cell class | 1.75e-04 | 182 | 127 | 5 | e95d946a43b1579af199900bb0e3eacbb9d65300 | |
| ToppCell | IPF-Epithelial-ATI|World / Disease state, Lineage and Cell class | 1.79e-04 | 183 | 127 | 5 | 31fef35ecf30162662f24d335d8f0cceacc07039 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.79e-04 | 183 | 127 | 5 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.79e-04 | 183 | 127 | 5 | e91f00b75d43ee6293fdd4a129b789cd95f8d11a | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.79e-04 | 183 | 127 | 5 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.84e-04 | 184 | 127 | 5 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.84e-04 | 184 | 127 | 5 | 9a185e6ea86bbfbb48bfe88650a8c05ceba78d7f | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-04 | 184 | 127 | 5 | f4344f3c407b2d4d703fe56e43d84dbfe60ba833 | |
| ToppCell | PCW_13-14-Immune_Lymphocytic-Immune_Lymphocytic_B-im_B_cell_(15)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.89e-04 | 185 | 127 | 5 | 8fc357ee041bfd588986730a52ea2021b5f88941 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.89e-04 | 185 | 127 | 5 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.89e-04 | 185 | 127 | 5 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 185 | 127 | 5 | 3f1aa91efae2d00320d126087cce1431ad5f26ea | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_atypical-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.89e-04 | 185 | 127 | 5 | 53960307c6710401c3d52a766c3f4704ace9637f | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.93e-04 | 186 | 127 | 5 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| Drug | AC1O5LBK | 8.35e-06 | 242 | 126 | 9 | CID006436256 | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Down 200; 7.2uM; PC3; HT_HG-U133A | 1.23e-05 | 193 | 126 | 8 | 5764_DN | |
| Drug | Nystatine [1400-61-9]; Down 200; 4.4uM; HL60; HT_HG-U133A | 1.48e-05 | 198 | 126 | 8 | 2500_DN | |
| Drug | Trimipramine maleate salt [521-78-8]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.48e-05 | 198 | 126 | 8 | 3342_UP | |
| Drug | D-cycloserine [68-41-7]; Down 200; 39.2uM; PC3; HT_HG-U133A | 1.60e-05 | 200 | 126 | 8 | 7134_DN | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 7.71e-06 | 10 | 120 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 7.71e-06 | 10 | 120 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.40e-05 | 12 | 120 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 5.63e-05 | 163 | 120 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | xeroderma pigmentosum (is_implicated_in) | 2.43e-04 | 6 | 120 | 2 | DOID:0050427 (is_implicated_in) | |
| Disease | xeroderma pigmentosum (implicated_via_orthology) | 2.43e-04 | 6 | 120 | 2 | DOID:0050427 (implicated_via_orthology) | |
| Disease | Profound Mental Retardation | 2.66e-04 | 139 | 120 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 2.66e-04 | 139 | 120 | 5 | C0025363 | |
| Disease | Mental deficiency | 2.66e-04 | 139 | 120 | 5 | C0917816 | |
| Disease | Malignant neoplasm of breast | NRIP1 DPYD NUP98 DGKG TACC2 SORCS1 NF1 PER3 CHD5 SYNE2 GALNT5 CLSPN DOP1A | 4.39e-04 | 1074 | 120 | 13 | C0006142 |
| Disease | Williams-Beuren syndrome (is_implicated_in) | 5.80e-04 | 9 | 120 | 2 | DOID:1928 (is_implicated_in) | |
| Disease | Xeroderma pigmentosum | 5.80e-04 | 9 | 120 | 2 | cv:C0043346 | |
| Disease | Colorectal Carcinoma | 6.05e-04 | 702 | 120 | 10 | C0009402 | |
| Disease | Cutaneous Melanoma | 6.25e-04 | 41 | 120 | 3 | C0151779 | |
| Disease | Autistic Disorder | 7.12e-04 | 261 | 120 | 6 | C0004352 | |
| Disease | T-cell acute lymphoblastic leukemia (is_implicated_in) | 8.81e-04 | 11 | 120 | 2 | DOID:5603 (is_implicated_in) | |
| Disease | Basal cell carcinoma | 8.81e-04 | 11 | 120 | 2 | C0007117 | |
| Disease | memory performance | 1.45e-03 | 409 | 120 | 7 | EFO_0004874 | |
| Disease | amygdala volume change measurement | 1.90e-03 | 16 | 120 | 2 | EFO_0021490 | |
| Disease | Intellectual Disability | 2.40e-03 | 447 | 120 | 7 | C3714756 | |
| Disease | Vertigo | 2.54e-03 | 139 | 120 | 4 | HP_0002321 | |
| Disease | smoking status measurement | DPYD IKZF2 ERCC4 RNMT TCF20 KCNH3 DLC1 PRELID2 ZNF804B PCDH15 PALS2 BTRC | 2.75e-03 | 1160 | 120 | 12 | EFO_0006527 |
| Disease | ceramide measurement | 2.79e-03 | 235 | 120 | 5 | EFO_0010222 | |
| Disease | Neutropenia | 3.27e-03 | 21 | 120 | 2 | C0027947 | |
| Disease | nucleotide measurement | 3.32e-03 | 73 | 120 | 3 | EFO_0010513 | |
| Disease | interleukin 18 measurement | 3.72e-03 | 76 | 120 | 3 | EFO_0004581 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DYNKISFKEQVPMPL | 236 | Q8IZL9 | |
| NDPRYMILNEPFKSE | 1761 | Q8TDI0 | |
| QAKKSYPMFPAPEER | 456 | Q9P2I0 | |
| FRPPNNEKLSLKFRM | 471 | P51589 | |
| LPIMTQPYDFKQLKS | 401 | Q8N157 | |
| TPTMKAKRPELRNYF | 671 | P33121 | |
| MPLSDFILALKDNPY | 1 | Q9Y276 | |
| YLKPMLQRDFITALP | 171 | Q9Y297 | |
| LPPENLSNLRYLMKF | 391 | Q9Y3L3 | |
| LMDKKLPSFGPYLEQ | 871 | Q12882 | |
| SPILYSNAFPNKDMK | 2421 | Q5JWR5 | |
| TMERYLKQIQDLPPT | 191 | Q9Y259 | |
| ARLQYLKMAFPELPE | 231 | Q9NPF8 | |
| KPDEEPLYMNLQKLL | 286 | Q8IWA6 | |
| KAANDPLMRAELQPY | 246 | Q8IYR0 | |
| KSPENFQYLRMDAEP | 36 | A6NCS4 | |
| MQLPELPKDISYKRY | 206 | P23458 | |
| VPMLNPSIYSLRNKD | 281 | Q96RC9 | |
| PKPLKQRMLEYFQAT | 531 | Q9ULD8 | |
| FNPDPDAETLYKAMK | 21 | P13928 | |
| RKPDEDMKLYQTPLE | 1206 | P52948 | |
| PFLNPLIYSLRNKDM | 301 | Q8NGC7 | |
| APYLEIKKQMDKQDP | 621 | Q8N3A8 | |
| QYLNKLSMKPEPLFR | 386 | P46821 | |
| DKYQNPFTMPVAILL | 446 | Q3B7T1 | |
| ILTEAIPPKMNQFLY | 176 | Q9BQP9 | |
| QYFKVKPQASALEMP | 371 | Q9NVF9 | |
| ERLFPQLLMKPDYNV | 801 | Q9P2D6 | |
| EMKKYFPSERRNKPS | 61 | P56645 | |
| YKKPEERSPLVAAMQ | 161 | O95373 | |
| NPLIYTLRNKDMKDA | 286 | Q9Y3N9 | |
| QALFPPSKRKMESLY | 221 | P41247 | |
| MPDPKQKAEELYQKR | 391 | O14511 | |
| KLFPYDPYERARQKM | 101 | Q9H4Y5 | |
| KGKPNPDQRYFMLVV | 356 | Q96LU7 | |
| MEPSLKYINKKFPNI | 51 | P55160 | |
| LYTEPLENPFKKMKN | 861 | P48552 | |
| FPYLMAVLTPKSNRK | 36 | Q6UX53 | |
| FPNENLPSKMLLVYD | 176 | Q9BRS8 | |
| KPELRPFYNMKPLSE | 286 | Q6W3E5 | |
| PFYNMKPLSEADKER | 291 | Q6W3E5 | |
| DDVFMPLYPKNVLEN | 746 | Q9Y5B6 | |
| LNPKRKQSPAYMKED | 426 | Q9UKS7 | |
| VRRYMQKVKNPPDED | 396 | Q86Y01 | |
| YMLSPKPQKKFVDQA | 431 | O95800 | |
| TPMLNPFIYSLRNKD | 331 | Q8NH94 | |
| PFDSNYFRKTPRLMK | 71 | O75344 | |
| IYEEVAKMPPFQRKT | 326 | Q9NZW5 | |
| VKDMNDYPPVFSKRI | 916 | Q96QU1 | |
| LYAFMPARSQDPKKP | 431 | Q8NA61 | |
| KLFMRAYLEVDLPQP | 56 | P49619 | |
| FDPNNYLPKESMLKT | 661 | P04114 | |
| PEYPDLLKKNNLMSL | 121 | Q8TE85 | |
| FNPDPDAETLYKAMK | 21 | Q5VT79 | |
| YDKDNIPPLTMKRIR | 2846 | Q8TD57 | |
| FNMKLHYKREKPLQP | 46 | Q8N5D6 | |
| RNDNPYSFPKDRMKT | 726 | Q7Z7M9 | |
| QDSIRKKYPCDKNMP | 396 | P15924 | |
| YDVPNPVFLEQKKML | 151 | Q16850 | |
| PPKTENELLQMFYRQ | 476 | Q92828 | |
| MQSDFFLPKPRKLRN | 866 | Q96RY5 | |
| NELKYFKDQMSPEPI | 191 | Q9UN19 | |
| DKDNIPPAYMNIIRK | 2756 | Q8WXX0 | |
| PLLTCIPNKRMNYFK | 321 | Q96H22 | |
| LYQLMKDRNKLFPES | 86 | P20794 | |
| LLKRMQALEPYPANE | 411 | O43148 | |
| ANKMAFRYPEPEDKA | 536 | P23368 | |
| KKLSNPFRYRMECPE | 126 | P09914 | |
| KMALDPYTELRKQPL | 206 | Q5JVL4 | |
| DYNPLMKDFPLNDLL | 331 | Q14204 | |
| NPMALYILKDKDSPE | 306 | Q14CZ8 | |
| NDPLLMTQYFKKSPS | 226 | Q6PJP8 | |
| YPNFIMDPKELDKVF | 506 | P42892 | |
| FTPKMYIIIAKPERN | 831 | Q13255 | |
| LRPSLDFDKMNQKPY | 296 | Q9NYF3 | |
| PIAKKARSNPQVYMD | 131 | Q9UNP9 | |
| PLDMEEKVRFKYPNT | 66 | O75170 | |
| LSSFLNDPNPMKYLR | 476 | Q9UPQ0 | |
| MKYLRQQSLPPPKFT | 486 | Q9UPQ0 | |
| NPMLNPLIYSLRNKE | 281 | A4D2G3 | |
| TPMLNPFIYSLRNKD | 281 | O60412 | |
| MYCDNRKLKTIPNIP | 76 | Q99983 | |
| LTPLFNPMIYSLRNK | 281 | Q8NGX5 | |
| DMAPTRKDKLLQFYP | 71 | Q9GZY6 | |
| CLPKQYLFTMKLQSP | 21 | Q96Q11 | |
| EDNYKNIKRPPGDIM | 256 | Q53GS9 | |
| FQPPKRPFKRMNYSD | 381 | O43776 | |
| LQFYLNKMKTFEEPP | 1601 | Q8WXH0 | |
| QPEMDLFLKDYSPKL | 311 | Q7Z494 | |
| KRKPVLSLFDYEQLM | 981 | A1L390 | |
| LDYFPPLAIQDLKRM | 181 | Q9P2J5 | |
| PMLNPFIYSLRNKDI | 301 | Q6IFN5 | |
| YPSMKNALIPRIKNA | 481 | Q6P3W7 | |
| ATPMLNPFIYSLRNK | 281 | O14581 | |
| VVMQPEKFQSKYEPR | 356 | P13667 | |
| MAFKYQVLLCPRPKD | 106 | Q8WVF1 | |
| KQYFRDLPEPLMTNK | 1151 | Q96QB1 | |
| YMFTPKIEQLANPKA | 226 | Q9NP91 | |
| FLPYESQKLVRPIKM | 276 | Q8N1H7 | |
| ADLNKPLYIDTKMRP | 1241 | Q9UPX8 | |
| QHKPDKILIYNRPNM | 246 | Q9H6R3 | |
| SPMERFKEFQIKSYP | 326 | Q96M20 | |
| QYQALKPRLPLASMD | 886 | Q9HAW4 | |
| VMPPQFKKDLDSYLK | 2171 | A5YKK6 | |
| LRTQKKMYPQLTFAP | 196 | Q96PP4 | |
| NDLEMKNPKVPLYLN | 571 | A4D1E1 | |
| DKNMPKFNKIPFYLQ | 556 | Q8TAF3 | |
| VKAMRFPPKSYNKDL | 491 | O43242 | |
| FDVPQLNEYCKMPLK | 2491 | Q15413 | |
| SPALYPMLFNKLKNT | 926 | P21359 | |
| SFLRKYPNPMDKNVI | 21 | Q8N945 | |
| RKPDEQPKYEDNIYM | 1426 | Q9UQD0 | |
| PQDDDAPKKQALYLM | 2536 | O95359 | |
| MKQINLTDYPIPRKF | 831 | Q9UGU0 | |
| RVKMLVKFPAQYPNN | 426 | Q6PJI9 | |
| YPSKPLQLLQRETME | 56 | A0A0B4J280 | |
| LAKNVQYPKCRDMQP | 291 | P0C7H9 | |
| LKKLMYEDSQRPVPR | 1221 | Q01118 | |
| PLRVAKPNKYQFLVM | 1656 | Q9UI33 | |
| VMLQPFDYDPNEKSK | 71 | O95292 | |
| PTQLPQELDFKYVMK | 46 | Q5VWN6 | |
| SEKYNPGPQDFLLKM | 841 | Q92889 | |
| YASKNLEAMNPPLFL | 771 | Q14139 | |
| TLRPYQSPFMDREKK | 606 | Q01831 | |
| RNAFAQMKLPKYALP | 396 | Q8WY21 | |
| SKFIQDPEKYDPLFM | 1141 | Q8IWV8 | |
| PQDMDEKIRYKYPNI | 66 | Q5H9R7 | |
| PKYVKIFINLPRSMD | 191 | O43396 | |
| NSFVSCNRKMKPPYL | 371 | Q9C099 | |
| VKDMKDRYYQLPIPR | 356 | Q8N9H8 | |
| KYTMSPDLPQFLQAK | 1271 | P20929 |